| Officer | Age | In this role | Joined | 2025 pay | Source |
|---|---|---|---|---|---|
|
Pete O’Heeron, MSHA
Also a director
Founder, CEO and Chairperson
|
62 | Not stated | Not stated | $1,066,191 | |
|
Jason D. Davis
Chief Financial Officer
|
53 |
Since 2025
1 year
|
Not stated | Not reported | |
|
Hamid Khoja, Ph.D.
Chief Scientific Officer
|
57 |
Since 2021
5 years
|
Not stated | $654,070 | |
|
Ruben A. Garcia
General Counsel
|
49 |
Since 2024
2 years
|
Not stated | $626,800 |
Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.
From the proxy statement filed May 5, 2026 · updated by the 8-Ks of Jul 9, 2026 and Aug 24, 2026
| Director | Age | On board | Independent | Committees | Other public boards | 2025 pay | Source |
|---|---|---|---|---|---|---|---|
|
Pete O’Heeron
Board chair, CEO
|
62 |
2021
5 years
|
Not independent | None stated | None stated | Paid as CEO | |
|
Robert E. Hoffman
|
60 |
2021
5 years
|
Independent | None stated | TuHURA Biosciences, Inc., Esperion Therapeutics, Inc. | $483,657 | |
|
Richard Cilento, Jr.
|
64 |
2021
5 years
|
Independent |
Compensation
|
None stated | $84,316 | |
|
Victoria Niklas, M.D.
|
67 |
2021
5 years
|
Independent |
Audit
Nominating
|
None stated | $71,816 | |
|
Kathleen Rubins
Joined Jul 8, 2026
|
- | - | - |
Audit Committee
Compensation Committee
Governance and Nominating Committee
|
- | - | |
|
Leigh Steinberg
Joined Aug 20, 2026
|
- | - | - | - | - | - | |
|
Stacy Coen
Leaving at the meeting
|
55 |
2021
5 years
|
Independent |
Audit
Compensation
|
None stated | $84,316 |
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive. A director marked Joined was added by an 8-K; their row opens that 8-K, and a dash is a value it does not give.
Purchase of 177,000 shares of Common Stock and pre-funded warrants for up to 428,510 shares at $6.606 per share, with warrants for 605,510 shares issued under a securities purchase agreement dated November 18, 2025
Exercise of 53,750 pre-funded warrants and issuance of 53,750 shares of Common Stock
Company issued a note receivable to GK due January 14, 2027 with a 3.63% interest rate
Loading...
